{"title":"An interview with Bruno Scheller.","authors":"Fernando Alfonso","doi":"10.24875/RECICE.M26000565","DOIUrl":"10.24875/RECICE.M26000565","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 2","pages":"127-129"},"PeriodicalIF":1.5,"publicationDate":"2026-01-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343805/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Alfonso Jurado-Román, Jon Zubiaur, Mattia Basile, Guillermo Galeote, Santiago Jiménez-Valero, Javier Suárez de Lezo, Francisco Hidalgo, Ignacio Gallo, Ana Belén Cid-Álvarez, Neus Bellera, Bruno García Del Blanco, Borja Rivero Santana, Daniel Tebar, Ariana Gonzálvez, Raúl Moreno
{"title":"Design of the LUDICO study: effectiveness and safety of coronary laser in undilatable or uncrossable lesions.","authors":"Alfonso Jurado-Román, Jon Zubiaur, Mattia Basile, Guillermo Galeote, Santiago Jiménez-Valero, Javier Suárez de Lezo, Francisco Hidalgo, Ignacio Gallo, Ana Belén Cid-Álvarez, Neus Bellera, Bruno García Del Blanco, Borja Rivero Santana, Daniel Tebar, Ariana Gonzálvez, Raúl Moreno","doi":"10.24875/RECICE.M25000560","DOIUrl":"10.24875/RECICE.M25000560","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Excimer laser coronary atherectomy (ELCA) is increasingly used in complex percutaneous coronary interventions (PCI), particularly in cases of \"balloon failure,\" which includes both uncrossable and undilatable coronary artery lesions. Although these 2 scenarios represent distinct technical and clinical challenges, they are usually evaluated using the same safety and efficacy endpoints. As a result, there is a lack of specific evidence on the safety and efficacy profile of ELCA in each of these situations. Furthermore, the role of intracoronary imaging in optimizing ELCA use remains insufficiently defined.</p><p><strong>Methods: </strong>This will be an investigator-initiated, multicenter, single-arm, open-label, prospective observational study. Patients with an indication for PCI and undilatable (non-compliant balloon dilatation < 80% at burst pressure) or uncrossable (uncrossable with a \"small-profile balloon\" with adequate support, left to the operator's discretion) coronary artery lesions treated with ELCA will be included. Intravascular imaging will be highly advised and analyzed in a core laboratory. Device success, angiographical success, procedural success, clinical success and related complications will be evaluated. Patients will be postoperatively followed for 1 year and clinical events will be recorded.</p><p><strong>Conclusions: </strong>The LUDICO study will be a multicentre, prospective study of ELCA therapy in uncrossable or undilatable coronary lesions. The study aims to evaluate the safety and efficacy profile of ELCA in these lesions as well as the clinical results at the 1 year follow-up in this setting. (ClinicalTrials.gov: NCT07206082).</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"152-160"},"PeriodicalIF":1.5,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532093/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Darío G Borraz-Noriega, Joan F Andrés-Cordón, Elena Cañedo, Fernando Panchano-Castro, Edgar Fadeuilhe, Michele Trichilo, Victoria Vilalta, Eduard Fernández-Nofrerias, Oriol Rodríguez-Leor, Irene Santos-Pardo, Xavier Carrillo
{"title":"Clinical utility of thrombus aspiration using the Hunter catheter in patients with acute myocardial infarction: the Hunted registry.","authors":"Darío G Borraz-Noriega, Joan F Andrés-Cordón, Elena Cañedo, Fernando Panchano-Castro, Edgar Fadeuilhe, Michele Trichilo, Victoria Vilalta, Eduard Fernández-Nofrerias, Oriol Rodríguez-Leor, Irene Santos-Pardo, Xavier Carrillo","doi":"10.24875/RECICE.M25000556","DOIUrl":"10.24875/RECICE.M25000556","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Manual thrombectomy (MT) during primary percutaneous coronary intervention (PCI) aims to reduce thrombus burden. Our study evaluates the outcomes and predictors of successful MT.</p><p><strong>Methods: </strong>The Hunted registry is a retrospective, single-center cohort study including patients who underwent MT during PCI using the Hunter catheter from July 2020 through February 2022. MT success was defined as an angiographic reduction to a Thrombolysis in Myocardial Infarction (TIMI) thrombus grade of ≤ 2, with clinical follow-up for major adverse cardiovascular events.</p><p><strong>Results: </strong>Among 750 patients with acute myocardial infarction who underwent PCI, 401 (53%) received MT. The mean age of treated patients was 62 years (80% men). MT was effective in 327 patients (81.55%). Predictors of successful MT included larger vessel diameter (P < .001), high thrombus burden (TIMI grade ≥ 4 flow; P < .001), and non-circumflex target vessels (P < .001). Device-related complications occurred in 17 patients (4.3%). At follow-up, major adverse events occurred in 8.98% of patients at 1 year and in 9.97% at 2 years.</p><p><strong>Conclusions: </strong>In patients with ST-segment elevation myocardial infarction undergoing PCI, MT with the Hunter catheter in selected cases with high thrombus burden (TIMI grade ≥ 4 flow), non-circumflex target vessels, and vessel diameters > 2.5 mm, is a safe and effective technique with a low rate of complications.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"161-167"},"PeriodicalIF":1.5,"publicationDate":"2026-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532101/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diego Arriaga-Izabal, Francisco Morales-Lazcano, Adrián Canizalez-Román
{"title":"Out-of-hours presentation and 30-day myocardial infarction mortality in Mexico: a 2014-2023 retrospective study.","authors":"Diego Arriaga-Izabal, Francisco Morales-Lazcano, Adrián Canizalez-Román","doi":"10.24875/RECICE.M25000559","DOIUrl":"10.24875/RECICE.M25000559","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>Although acute myocardial infarction (AMI) remains a leading cause of death in Mexico, the impact of out-of-hours presentation on mortality remains understudied. The aim of this study was to evaluate the association between out-of-hours admissions (nights, weekends, holidays) and 30-day mortality in patients with AMI in Mexican hospitals, with a focus on the role of catheterization laboratories (cath lab).</p><p><strong>Methods: </strong>We conducted a retrospective cohort study to analyze emergency admissions from December 2014 through August 2023. Admissions were classified as out-of-hours or during-hours and were stratified by hospital type (with or without cath lab). Cox regression models adjusted for sociodemographic, health, and temporal variables were used to analyze mortality risks.</p><p><strong>Results: </strong>The study included a total of 29 131 cases: 4515 in percutaneous coronary intervention (PCI)-capable centers (group 1) and 24 616 in non-PCI-capable centers (group 2). Admissions outside regular hours accounted for 46.7% in group 1 and 53.6% in group 2. Adjusted analysis showed that although the presence of a cath lab was protective (HR, 0.25; 95%CI, 0.23-0.28), admissions outside regular hours increased the risk of mortality in both groups (group 1: HR, 1.25; 95%CI, 1.04-1.50; group 2: HR, 1.16; 95%CI, 1.11-1.22). Although overnight shifts increased the risk of death in both groups, weekends and holidays increased such risk only in non-PCI-capable centers.</p><p><strong>Conclusions: </strong>Out-of-hours admissions were associated with higher mortality, and unlike in developed countries, the presence of a cath lab did not improve out-of-hours outcomes.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"177-183"},"PeriodicalIF":1.5,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532099/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Filippo Pensotti, Luis Jorge Garnacho, Mario García-Gómez, Akash Jain, Marcelo Rodríguez, Mauricio Zuñiga, María Sandín-Fuentes, Alberto Campo, Carlos Cortés-Villar, Sara Blasco, Luis Llamas-Fernández, Sofía Campillo, J Alberto San Román, Ignacio J Amat-Santos
{"title":"Device console programming in patients undergoing TAVI with preexisting cardiac implantable electronic devices: a practical guide.","authors":"Filippo Pensotti, Luis Jorge Garnacho, Mario García-Gómez, Akash Jain, Marcelo Rodríguez, Mauricio Zuñiga, María Sandín-Fuentes, Alberto Campo, Carlos Cortés-Villar, Sara Blasco, Luis Llamas-Fernández, Sofía Campillo, J Alberto San Román, Ignacio J Amat-Santos","doi":"10.24875/RECICE.M25000561","DOIUrl":"10.24875/RECICE.M25000561","url":null,"abstract":"<p><p>Transcatheter aortic valve implantation (TAVI) is established as the standard of care for patients across all surgical risk profiles, with expanding indications in younger and lower-risk populations. A substantial proportion of patients eligible for TAVI have preexisting cardiac implantable electronic devices (CIED). Temporary transvenous right ventricular (RV) pacing is routinely used during TAVI to facilitate procedural safety but carries inherent risks, including RV perforation, cardiac tamponade, and lead dislodgement. Alternative pacing strategies, such as left ventricular pacing via the valve delivery guidewire, have been proposed to reduce procedural complications. In patients with a preexisting CIED, leveraging the implanted device for procedural pacing represents a rational and potentially safer option. However, its adoption remains limited, largely due to unfamiliarity with device-specific programming. This article provides a detailed, step-by-step practical guide for programming rapid ventricular pacing using the most widely encountered CIED platforms: Biotronik, Medtronic, Abbott/St. Jude, Sorin, and Boston Scientific. The specific programming pathways for each manufacturer are summarized to facilitate safe, effective, and reproducible implementation during TAVI.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"184-189"},"PeriodicalIF":1.5,"publicationDate":"2026-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532105/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931377","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Victor Arévalos, Anthony Salazar-Rodríguez, Guillermo Velázquez, Javier Galeano, Osmar Antonio Centurión, Andrea Ruberti, Raquel Luna-López, Igor Morr-Verenzuela, Pedro Cepas-Guillén, Sílvia Montserrat, Susanna Prat-González, Bárbara Vidal, Laura Sanchis, Íñigo Anduaga, Alejandro Fernández-Cisneros, Daniel Pereda, Ricardo Sanz-Ruiz, Juan M Carretero Bellón, Ander Regueiro, Omar Abdul-Jawad Altisent, Salvatore Brugaletta, Manel Sabaté, Eduardo Flores-Umanzor, Xavier Freixa
{"title":"Transcatheter treatment of aortic coarctation.","authors":"Victor Arévalos, Anthony Salazar-Rodríguez, Guillermo Velázquez, Javier Galeano, Osmar Antonio Centurión, Andrea Ruberti, Raquel Luna-López, Igor Morr-Verenzuela, Pedro Cepas-Guillén, Sílvia Montserrat, Susanna Prat-González, Bárbara Vidal, Laura Sanchis, Íñigo Anduaga, Alejandro Fernández-Cisneros, Daniel Pereda, Ricardo Sanz-Ruiz, Juan M Carretero Bellón, Ander Regueiro, Omar Abdul-Jawad Altisent, Salvatore Brugaletta, Manel Sabaté, Eduardo Flores-Umanzor, Xavier Freixa","doi":"10.24875/RECICE.M25000557","DOIUrl":"10.24875/RECICE.M25000557","url":null,"abstract":"<p><p>Aortic coarctation is a congenital disease that consists of the narrowing of the thoracic aorta, leading to distal blood flow obstruction. Significant aortic coarctation is associated with hypertension and distal hypoperfusion, with a poor prognosis without intervention. Initially, treatment was surgical; however, less invasive techniques such as percutaneous balloon angioplasty later emerged and proved effective in selected patients. The introduction of stent implantation significantly improved the outcomes, making percutaneous repair the preferred option, especially in adolescents and adults. However, immediate and long-term complications persist, which has driven research efforts aimed at improving the safety and efficacy profile. Modern strategies now focus on advanced stent designs, offering better delivery profiles and high redilatation potential. Gaps in knowledge remain, and data from studies with longer follow-up will be essential to further elucidate disease progression in these patients. This review aims to offer a comprehensive overview of these percutaneous procedures, discussing recent advancements, clinical outcomes, and future perspectives.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 2","pages":"107-115"},"PeriodicalIF":1.5,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148976799","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Flavia Di Cosmo, Lucas Barreiro Mesa, Martín Ruiz Ortiz, Cristina Urbano Sánchez, Manuel Pan Álvarez-Ossorio, Dolores Mesa Rubio
{"title":"Outcomes of edge-to-edge mitral valve repair in patients with mitral regurgitation evaluated for heart transplantation.","authors":"Flavia Di Cosmo, Lucas Barreiro Mesa, Martín Ruiz Ortiz, Cristina Urbano Sánchez, Manuel Pan Álvarez-Ossorio, Dolores Mesa Rubio","doi":"10.24875/RECICE.M25000554","DOIUrl":"10.24875/RECICE.M25000554","url":null,"abstract":"","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 3","pages":"190-193"},"PeriodicalIF":1.5,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13532091/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148931430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Miguel Á Martín-Arena, Guillermo Galeote-García, Alejandro Lara-García, Alfonso Jurado-Román, Santiago Jiménez-Valero, Ariana Gonzálvez-García, Daniel Tébar-Márquez, Borja Rivero-Santana, Jon Zubiaur, Mattia Basile, Silvia Valbuena-López, Lucía Fernández-Gassó, Regina Dalmau González-Gallarza, Raúl Moreno
{"title":"Embolization of left atrial appendage occluders: review of the current evidence.","authors":"Miguel Á Martín-Arena, Guillermo Galeote-García, Alejandro Lara-García, Alfonso Jurado-Román, Santiago Jiménez-Valero, Ariana Gonzálvez-García, Daniel Tébar-Márquez, Borja Rivero-Santana, Jon Zubiaur, Mattia Basile, Silvia Valbuena-López, Lucía Fernández-Gassó, Regina Dalmau González-Gallarza, Raúl Moreno","doi":"10.24875/RECICE.M25000547","DOIUrl":"10.24875/RECICE.M25000547","url":null,"abstract":"<p><p>Percutaneous left atrial appendage closure has emerged as a promising procedure for patients with non-valvular atrial fibrillation with a very high or prohibitive bleeding risk. It is a safe technique, with a low rate of complications; however, complications, such as device embolization can be potentially serious, and decision-making as well as selecting the most appropriate strategy may be challenging due to the limited evidence available in this context. This review provides an overview of the most critical aspects of left atrial appendage closure device embolization focusing on its prevalence, management strategies, and treatment options.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 1","pages":"46-54"},"PeriodicalIF":1.5,"publicationDate":"2025-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13137347/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147843726","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Carmen Vidau Getán, Domingo López Vázquez, Xacobe Flores Ríos, Borja Souto Caínzos, Fernando Rebollal Leal, Pablo Piñón Esteban, Guillermo Aldama López, Jorge Salgado Fernández, Miguel González Montes, Gabriel González Barbeito, Ramón Calviño Santos, José Manuel Vázquez Rodríguez
{"title":"How does major bleeding influence decision-making in patients eligible for transfemoral TAVI? A single-center experience.","authors":"Carmen Vidau Getán, Domingo López Vázquez, Xacobe Flores Ríos, Borja Souto Caínzos, Fernando Rebollal Leal, Pablo Piñón Esteban, Guillermo Aldama López, Jorge Salgado Fernández, Miguel González Montes, Gabriel González Barbeito, Ramón Calviño Santos, José Manuel Vázquez Rodríguez","doi":"10.24875/RECICE.M25000548","DOIUrl":"10.24875/RECICE.M25000548","url":null,"abstract":"<p><strong>Introduction and objectives: </strong>To evaluate the impact of bleeding on the risk-benefit balance of coronary revascularization prior to transfemoral transcatheter aortic valve implantation (TF-TAVI).</p><p><strong>Methods: </strong>We conducted a retrospective analysis of the patients who underwent TF-TAVI at our center between 2008 and 2018 to evalute the management of coronary artery disease (percutaneous revascularization vs no revascularization). Subsequently, the rate of major bleeding -defined according to the Bleeding Academic Research Consortium (BARC) criteria (type 3-5)- and major adverse cardiovascular events (MACE) was compared between the 2 groups over a mean 60-month follow-up period.</p><p><strong>Results: </strong>A total of 379 patients were included. The overall rate of major bleeding was 21.4%, higher in revascularized patients but without reaching statistical significance. The rate of major bleeding between coronary angiography and TF-TAVI implantation was 5.5% and significantly higher in revascularized patients (12.0% vs 3.5%; P = .07). During the hospitalization for TF-TAVI and throughout follow-up, the rate of major bleeding was 6.1% and 9.6%, respectively, with no significant inter-group differences. There were no significant differences either in the 5-year rate of MACE.</p><p><strong>Conclusions: </strong>In our patient cohort, pre-TF-TAVI preoperative coronary revascularization was associated with an initially higher bleeding risk; however, no statistically significant differences were observed in major bleeding or MACE at the 5-year follow-up. These findings support the need to generate high-quality clinical evidence to demonstrate the net clinical benefit of coronary revascularization in this context.</p>","PeriodicalId":34295,"journal":{"name":"REC Interventional Cardiology","volume":"8 2","pages":"79-84"},"PeriodicalIF":1.5,"publicationDate":"2025-12-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13343803/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148978224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}